Replay available

Avanos Medical, Inc. (AVNS) Q3 2024 Earnings Call

Avanos Medical, Inc. (NYSE: AVNS) Q3 2024 earnings conference call, held 2024-10-30. Replay captured from the company's public earnings webcast.

Wed, October 30, 2024 at 9:00 AMendedReplay
Avanos Medical, Inc. (AVNS) Q3 2024 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Scott Gullivan

SVP Strategy and Corporate Development

Gary Blackford

Avanos Board Chair

Michael Greiner

Interim CEO

Kristen Stewart

Analyst at CL King

Danny Sautter

Analyst at JMP Securities

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Avanos Medical Avanos Third Quarter 2024 Earnings Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Wednesday, October 30th, 2024. I would now like to turn the conference over to Scott Gullivan, SVP Strategy and Corporate Development. Please go ahead. Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to Avanos 2024 Third Quarter Earnings Conference Call. Speaking first today will be Gary Blackford, Avanos Board Chair. He'll be followed by Interim CEO Michael Greiner. Gary will give an update on our leadership changes before Michael reviews our third quarter results, the current business environment, an update on our transformation efforts and our fourth quarter 2024 planning assumptions. We will finish the call with Q&A. A presentation for today's call is available on the Investors section of our website, avanos.com. As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, current economic conditions, and our industry. No assurance can be given as to future financial results. Actual results could differ materially from those in the forward-looking statements. For more information about forward-looking statements and the risk factors that could influence future results, please see today's press release and risk factors described in our filings with the SEC. Additionally, we will be referring to adjusted results and outlook. The press release has information on these adjustments and reconciliations to comp...

More from Avanos Medical, Inc.